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Symposium:
Clinical Trials and Access to Essential
Medicines in African Countries
Access to Essential Medicines in African
Countries: An Introduction
PETER G. DANCHIN† AND DIANE HOFFMANN††

The concept of a human right to health was first recognized internationally by the World Health Organization in 1946 when it declared
that “the enjoyment of the highest attainable standard of health is one
of the fundamental rights of every human being without distinction of
race, religion, political belief, economic or social condition.”1 Since
that time, the right has become encoded and entrenched in both conventional and customary international law.
Article 25 of the Universal Declaration of Human Rights (1948)
recognizes the right to health as part of an adequate standard of living
closely linked with other economic and social rights such as “food,
clothing, housing and medical care and necessary social services.”2
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1. Economic and Social Council, Constitution Adopted by the United States of America
and Other Governments respecting a World Health Organization 62 Stat. 2679, 14 U.N.T.S.
185 (June 21, 1948) (establishing the World Health Organization, originally signed 22 July
1946).
2. Universal Declaration of Human Rights, G.A. Res. 217 A (III), U.N. GAOR, 3d Sess.,
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Today, the locus classicus of the right in international law is Article 12
of the International Covenant on Economic, Social and Cultural Rights
(1976) which provides that States Parties recognize “the right of everyone to the enjoyment of the highest attainable standard of physical
and mental health” and that steps are to be taken in order to realize the
right in the areas of (a) reduction of the still-birth rate and infant mortality; (b) improvement of environmental and industrial hygiene; (c)
prevention, treatment and control of diseases; and (d) creation of conditions assuring to all medical service and attention in the event of
sickness.3 Various other international and regional human rights instruments have similar provisions.4
It was within the context of tackling the global HIV/AIDS crisis
in the 1990s that the first practical and theoretical linkages started to
be made between the fields of health and human rights. At a normative
level, a key breakthrough occurred in 2000 when the UN Committee
on Economic, Social and Cultural Rights issued General Comment 14
on the right to health which had the effect of providing authoritative
guidance on the scope and content of the right as well as ushering in a
new era of work. The focus of the General Comment is on the interrelated and essential elements of availability (sufficient quantity); accessibility (physical, economic and non-discrimination); acceptability
(being respectful of medical ethics and being culturally appropriate);
and quality (scientifically and medically appropriate). The committee
further sought to give legal content to the obligations assumed by
States (1) to respect (all persons and without interference to traditional
care); (2) to protect (with legislative and other measures and include
no restrictions to access); and (3) to fulfill (with positive measures in
national, political, legal, and policy systems) the right to health.
Since the early 2000s, numerous UN and regional human rights
reports have explored how to operationalize the right to health according to these criteria. This has required translating legal standards into
the design and functioning of entire health systems so as to ensure not

1st plen. mtg., U.N. Doc. A/810 (Dec. 12, 1948), art. 25.
3. G.A. Res. 2200 (XXI) A, annex, International Covenant on Economic, Social and
Cultural Rights, art. 12 (Dec. 16, 1966).
4. European Social Charter art. 11, opened for signature Oct. 18, 1961, E.T.S. No. 035
(entered into force Feb. 26, 1965); Organization of American States [OAS] Res. XXX, American Declaration of the Rights and Duties of Man, art. 11 (May 2, 1948); Org. of African Unity
[OAU], African Charter on Human and Peoples’ Rights art. 16, June 17, 1981, OAU Doc.
CAB/LEG/67/3 rev. 5, 21 ILM. 58 (1982); G.A. Res. 44/25, Convention on the Rights of the
Child, art. 23–4 (Nov. 20, 1989); G.A. Res. 34/180, Convention on the Elimination of Discrimination Against Women, art. 12 (Dec. 18, 1979).
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merely the identification of violations ex ante but the upfront promotion and protection of the right. The key elements in this normative
development of the right can be traced through the reports of the successive UN Special Rapporteurs on the right to health and, in particular, the widely regarded reports of Paul Hunt written between 2002–
2008. Three elements, in particular, are discernable.
First, a concern not only with outcomes (such as provision of essential medicines and safe drinking water) but also with process (e.g.,
transparency, participation, and non-discrimination). Second, the realization that the health of individuals, communities and populations
requires more than medical care but also a focus on the underlying determinants of health such as access to safe water, adequate sanitation,
an adequate supply of food and housing, healthy environmental conditions, and health-related education. And third, the proposition that the
right gives rise to legally binding obligations on States, especially the
obligation to ensure that its health system includes certain features and
measures such as a comprehensive national plan and a minimum basket of health-related services and facilities.5
The key question addressed in this Symposium6 is how exactly
access to essential medicines is recognized and operationalized in both
theory and practice as part of the human right to health, and what barriers exist—historical, political, legal and socioeconomic—to the realization of this right in the specific context of states in southern Africa.
In particular, how might international legal regimes, in the areas of
trade and intellectual property, pose obstacles to access to essential
medicines in African countries.7
The genesis of the Symposium lies in a remarkable collaboration
that has developed between Chancellor College Faculty of Law in
Zomba, Malawi and the University of Maryland Frances King Carey
School of Law in Baltimore, Maryland, United States which began in
2010 when the Global Health Interprofessional Council (GHIC) at the
University of Maryland first sent a multidisciplinary team of faculty
5. For a comprehensive discussion of the right-to-health approach to strengthening
health systems, see Gunilla Backman, Paul Hunt et al., Health Systems and the Right to Health:
An Assessment of 194 Countries, 372 LANCET 2047 (2008).
6. The Symposium on Clinical Trials and Access to Essential Medicines in African
Countries was held at the University of Maryland Frances King Carey School of Law on October 29–30, 2015.
7. Other topics addressed at the Symposium included the law and ethics of clinical trials
and the obligations owed to host communities by clinical researchers and sponsors. These
papers are published in a parallel symposium issue of the Journal of Health Care Law and
Policy, volume 19 (2016).
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and students to Malawi to study the health and legal rights of orphans
and vulnerable children. Since then, successive visits of students and
faculty have been made and, in 2013, the International & Comparative
Law and Law & Health Care Programs at Maryland Law School
teamed up to organize a series of lectures and a workshop at Chancellor
College on the right to health and HIV/AIDS, as well as to discuss the
HIV/AIDS legal clinics at the two schools.8
The articles published following this Symposium reflect the
unique and interdisciplinary nature of this collaboration. The first article by Lucie White, Getting Real About Essential Medicines: “The
Last Kilometer,”9 squarely addresses the question of what it means to
realize the human right to essential medicines. White begins with the
hypothetical story of A, an eighteen-year-old girl in a West African
nation, who develops a form of mental illness. Her point is that the
vantage point from which to evaluate the right to essential medicines
must be “where the people who need the drug actually stand.”10 Realization of the right, in other words, must be assessed from the perspective of the rights holders’ themselves, and this requires a systemic perspective on “the institutions and systems that failed to deliver the
medicine that ‘last kilometer’ to the people who need them.”11
White seeks to reframe the right to essential medicines as a “call
for pragmatic action” that “addresses the treatment challenge from the
bottom up and top down, so as to connect people with what they need
to maintain wellbeing, even while sick, not through drugs alone, but
through drugs within systems of care.”12 In doing so, she challenges
four aspects of the contemporary debate. First, the concept of essential
medicines “since its origins has been constrained within a formalistic
frame.”13 Second, the “dominant frame for understanding human rights
has been similarly formalistic” and thus any hoped-for convergence
between rights doctrine and access to essential medicine policy has

8. Further exchange visits were organized in 2015 in relation to the Access to Justice
clinic at the Maryland Law School and spanned issues of criminal justice reform, effective
assistance of counsel, and bail.
9. Lucie White, Getting Real About Essential Medicines: “The Last Kilometer,”31 MD.
J. INT’L L. 79 (2016).
10. Id. at 81.
11. White here cites Paul Farmer’s notion of “structural violence” describing the social
arrangements embedded in forms of political and economic organization that cause injury to
people. See Paul Farmer, Structural Violence and Clinical Medicine, 3 PLOS MED. 1686
(2006).
12. White, supra note 9, at 81.
13. Id. at 87.

DANCHINHOFFMANNINTROFINALBOOKPROOF (DO NOT DELETE)

2016]

SYMPOSIUM INTRODUCTION

2/22/2017 1:40 PM

5

been undermined.14 Third, the movement for HIV/AIDS treatment, in
effect, reframed the right to essential medicines from “a formalistic
conception into a call for social movement and pragmatic action for
change”15 (as reflected, for example, in the landmark decision of the
South African Constitutional Court in Minister of Health v. TAC).16
And finally, a “public health movement that embeds within it the right
to essential medicines can transform the demand for ‘access to essential medicines’ into a call—and a movement—for holistic systems of
care.”17
The second article by Danwood Chirwa, Access to Medicines and
Health Care in Sub-Saharan Africa: A Historical Perspective,18 discusses a vital and usually ignored dimension of the challenge of improving access to essential medicines and medical care in African
states: an historical account of the problem and the need to understand
the “historical genesis and context” of these challenges. Chirwa addresses five broad periods in his analysis of the nature of health care
systems in Africa: first, the pre-colonial period and the ways in which
approaches to health were “intricately linked to African communitarian philosophy and beliefs”;19 second, the simultaneously “modernizing” and “marginalizing” impact of Christian missionaries during the
period of colonialism in the late nineteenth century; third, the legal,
political and economic changes effected by African nationalists in the
post-independence period which both sought to extend medical services to rural areas while leaving the colonial health system in place
and ultimately resulted in “an uneasy relationship between traditional
medicine and African customs and traditions, on the one hand, and
western medicine and the received law, on the other”;20 fourth, the negative economic impact of the implementation by African governments
of structural adjustment programs in the third and fourth decades following independence; and finally, the generally positive effects on
health policy of the far-reaching democratization and constitutional reforms of the 1990s, especially regarding the acceptance of economic,
social and cultural rights.
The third article by Lisa Forman, The Inadequate Global Policy
14. Id.
15. Id.
16. (2002) (5) SA 721 (CC).
17. White, supra note 9, at 87.
18. Danwood Chirwa, Access to Medicines and Health Care in Sub-Saharan Africa: A
Historical Perspective, 31 MD. J. INT’L L. 21 (2016).
19. Id. at 23.
20. Id. at 29.
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Response to Trade-Related Intellectual Property Rights: Impact on Access to Medicines in Low- and Middle-Income Countries,21 shifts focus
to the question of how trade and intellectual property rules and regimes
themselves may operate in international law to derogate the rights to
health and life protected in international and regional human rights
treaties. Forman analyzes, in particular, the World Trade Organization’s Agreement on Trade Related Aspects of Intellectual Property
(TRIPS Agreement)22 and the increasing use by states of bilateral and
free trade agreements (FTAs). The inaccessibility of essential medicines in low- and middle-income countries under the strictures of these
regimes suggests that exiting global policy initiatives have failed and
that “bolder measures” are needed if the drug gap is to be remediated.
For Forman, this must take the form not merely of TRIPS flexibilities
(which “turn the fundamental human right to health and affordable
medicines into a rigidly restricted exception to a property right”)23 but
actual suspension of the application of trade-related intellectual property rights to essential drugs for affected countries in southern Africa.
If this is to occur, the impetus must come from social actors and movements.
The final article by Chikosa Banda, Intellectual Property and Access to Essential Pharmaceuticals: Recent Law and Policy Reforms in
the Southern Africa Development Community Region,24 continues the
focus on the 1994 TRIPS Agreement and the significant barriers this
regime poses to access to essential medicines in developing countries.
Banda explores in depth the various flexibilities, transition periods,
waivers and exemptions potentially available to “least-developed
countries” in terms of TRIPS compliance. He suggests that these flexibilities do offer countries in the southern African region “some policy
space to facilitate the development of local production capacity” and
that this can be “done through the creation of legal environments that
permit the copying and imitation of technologies.”25
Most discussions and reforms to date, however, have focused on
21. Lisa Forman, The Inadequate Global Policy Response to Trade-Related Intellectual
Property Rights: Impact on Access to Medicines in Low- and Middle-Income Countries, 31
MD. J.INT’L L. 8 (2016).
22. Agreement on Trade-Related Aspects of Intellectual Property Rights, Apr. 15, 1994,
Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, 1869 U.N.T.S.
299.
23. Id. at 19.
24. Chikosa Banda, Intellectual Property and Access to Essential Pharmaceuticals: Recent Law and Policy Reforms in the Southern Africa Development Community Region, 31 MD.
J. INT’L L. 44 (2016).
25. Id. at 49.
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facilitating the importation of essential medicines from countries such
as India, rather than on spurring local and regional innovation and production of pharmaceuticals. Banda’s thesis is that importation of generic, essential medicines is at best a short- and medium-term solution
and that countries in the region must move towards local production in
order to achieve a sustainable long-term solution. While the structural
and fiscal challenges to pharmaceutical innovation and access are
“multiple and multifaceted,” and while much “policy incoherence” remains in and between national laws, countries in the region are “increasingly becoming aware of the need to find sustainable solutions to
the problem of how to access pharmaceutical products” and this realization is slowly leading to patent law reforms aimed at domesticating
TRIPS flexibilities and harnessing of economies of scale in order to
stimulate local and regional production.26
These are vastly complex and difficult questions and, as the articles in the Symposium so vividly illustrate, the struggle to realize the
right of access to essential medicines in African countries is, in many
respects, just beginning. Two strong themes, in particular, emerge:
first, that much reigning neoliberal orthodoxy in the field of health and
human rights needs urgently to be rethought and political space opened
up to reconnect issues of poverty and human rights as matters of justice
(not merely policy); and second, that gross violations of the right to
health require us to look beyond immediate local and national contexts
and to examine more critically the interconnected history, political
economy and powerful transnational institutions that continue to shape
the health-related laws and policies in post-colonial African states.

26. Id. at 53–55, 73.

